China

AB-Biotics to launch gastropaedriatric probiotic with Derbycare

By RJ Whitehead

- Last updated on GMT

AB-Kolicare reduces excessive crying as a result of baby colic
AB-Kolicare reduces excessive crying as a result of baby colic

Related tags China Infant Probiotic

AB-Biotics, the Spanish biotech company, and leading Chinese women and infant nutrition player Derbycare will launch a gastropaediatric health product in China this year.

Before the launch, Derbycare will develop three new clinical trials with a minimum of 3,000 patients to cement the claims of the product, AB-Kolicare. 

Among these is the reduction of excessive daily crying in two-thirds subjects over 14 days, according to an AB-Biotics clinical trial.

Derbycare and AB-Biotics will also collaborate on the development of new probiotic formulas and food supplements rich in probiotics for infants which Derbycare will market in China and other markets.

Derbycare owns a paediatric nutrition research institute with an independent expert committee and an advisory team including representatives from major Chinese hospitals.

"This agreement allows AB-Biotics to enter the Chinese paediatric market with an excellently positioned partner that will also allow us to develop new innovative solutions thanks to its excellent research institute​", said Miquel Angel Bonachera and Sergi Audivert,​ chief executives of of AB-Biotics.

Jason Shen, executive director of Derbycare, responded: “Derbycare will work closely with AB-Biotics to promote the probiotic products among the maternity and 0-3 infant population in China, a 70m population who know little about probiotics and seldom use them. This is a huge opportunity.​”

Related news

Follow us

Products

View more

Webinars

Food & Beverage Trailblazers

F&B Trailblazers Podcast